Novateor Research Laboratories Financial Statements
Novateor Research Laboratories financial statements. In FYNone, Novateor Research Laboratories (NOVATEOR) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse Novateor Research Laboratories ownership pattern to track promoter, FII and institutional holdings.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
NOVATEOR Revenue, Net Profit & EBITDA — Year-on-Year Growth
NOVATEOR YoY (March 2026 vs Period) — revenue -100.0%, expenses -100.0%. Read Novateor Research Laboratories dividend payments for the complete payout history and dividend yield track record.
NOVATEOR Income Statement — Revenue, EBITDA & Net Profit
Novateor Research Laboratories revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None). For live price, earnings ratios and company overview, see NOVATEOR screener.
| Particulars | None | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 4 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 4 | 3 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit Margin % | -39.00% | -3.00% | -5.00% | -27.00% | -28.00% | -25.00% | -176.00% | -35.00% | 71.00% | 59.00% | 42.00% | -6.00% | 2.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 0.00 | 0.17 | 0.17 | 0.06 | 0.08 | -0.47 | 0.02 | -0.02 | 0.74 | 0.18 | -0.62 | 0.05 | 0.30 |
NOVATEOR Balance Sheet — Assets, Liabilities & Shareholders' Equity
NOVATEOR total assets ₹14 Cr, total equity ₹12 Cr, total liabilities ₹ Cr (2026).
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 14 | 13 | 11 | 9 | 8 | 9 | 9 | 4 | 2 | 2 | 2 | 2 |
| Current Assets | 11 | 9 | 8 | 7 | 6 | 6 | 5 | 1 | 0 | 0 | 0 | 0 |
| Fixed Assets | 3 | 3 | 2 | 2 | 2 | 3 | 4 | 4 | 2 | 2 | 2 | 2 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 11 | 9 | 8 | 7 | 6 | 6 | 5 | 1 | 0 | 0 | 0 | 0 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 12 | 11 | 9 | 8 | 8 | 9 | 9 | 4 | 1 | 1 | 1 | 1 |
| Share Capital | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 3 | 0 | 0 | 0 | 0 |
| Reserves & Surplus | 6 | 3 | 4 | 3 | 3 | 4 | 4 | 1 | 1 | 1 | 1 | 1 |
NOVATEOR Cash Flow Statement — Operating, Investing & Financing
Novateor Research Laboratories operating cash flow ₹0 Cr, investing ₹-1 Cr, financing ₹1 Cr, net cash flow ₹0 Cr (2026).
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | -1 | -1 | -1 | -1 | 0 | -3 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | -1 | 0 | 0 | 0 | 1 | 0 | 0 | -2 | 0 | 0 | 0 | 0 |
| Financing Activities | 1 | 1 | 1 | 1 | 0 | 0 | 4 | 2 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |